| Literature DB >> 36203650 |
Lizeth Cifuentes1, Maria Daniela Hurtado A1,2, Jeanette Eckel-Passow3, Andres Acosta1.
Abstract
Obesity is a multifactorial disease with a variable and underwhelming weight loss response to current treatment approaches. Precision medicine proposes a new paradigm to improve disease classification based on the premise of human heterogeneity, with the ultimate goal of maximizing treatment effectiveness, tolerability, and safety. Recent advances in high-throughput biochemical assays have contributed to the partial characterization of obesity's pathophysiology, as well as to the understanding of the role that intrinsic and environmental factors, and their interaction, play in its development and progression. These data have led to the development of biological markers that either are being or will be incorporated into strategies to develop personalized lines of treatment for obesity. There are currently many ongoing initiatives aimed at this; however, much needs to be resolved before precision obesity medicine becomes common practice. This review aims to provide a perspective on the currently available data of high-throughput technologies to treat obesity.Entities:
Keywords: ADOPT; genetics; microbiome; phenotypes
Year: 2021 PMID: 36203650 PMCID: PMC9534386 DOI: 10.1055/s-0041-1729945
Source DB: PubMed Journal: Dig Dis Interv ISSN: 2472-8721